HF
AQST icon

HRT Financial’s Aquestive Therapeutics AQST Stock Holding History

HRT Financial’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
+344,811
New +$1.45M ﹤0.01% 1939
2026
Q1 		– Sell
-994,966
Closed -$6.43M – 3746
2025
Q4 		$6.43M Buy
994,966
+434,757
+78% +$2.71M 0.02% 660
2025
Q3 		$3.13M Buy
+560,209
New +$2.42M 0.01% 908
2025
Q2 		– Sell
-16,048
Closed -$46K – 2564
2025
Q1 		$46K Sell
16,048
-26,128
-62% -$79.1K ﹤0.01% 2244
2024
Q4 		$150K Buy
+42,176
New +$194K ﹤0.01% 1994
2024
Q2 		– Sell
-285,360
Closed -$1.22M – 2185
2024
Q1 		$1.22M Buy
+285,360
New +$950K 0.01% 795
2021
Q3 		– Sell
-49,907
Closed -$198K – 3249
2021
Q2 		$198K Buy
+49,907
New +$199K ﹤0.01% 2391
2021
Q1 		– Sell
-19,521
Closed -$104K – 2662
2020
Q4 		$104K Buy
+19,521
New +$117K ﹤0.01% 1629

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

HRT Financial's AQST Position: Q2 2026 in Review

HRT Financial opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 344,811 shares worth $1.43M. The stake represents ﹤0.01% of the portfolio and ranks #1939 among its holdings. This is a return to the name: HRT Financial previously reported a position in AQST as recently as Q4 2025.

HRT Financial first reported a position in AQST in Q4 2020 and has held it in 8 quarters since. The position peaked at $6.43M in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • HRT Financial held 344,811 shares of Aquestive Therapeutics worth $1.43M as of Q2 2026.
  • Aquestive Therapeutics was a new HRT Financial position in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1939 holding.
  • HRT Financial first reported a position in Aquestive Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • HRT Financial's Aquestive Therapeutics position peaked at $6.43M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.